Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure

Journal of Nephrology

Volumn 15, Issue 6, 2002, Pages 643-648

  Cottone, Santina ^a   Mulè, Giuseppe ^a   Amato, Felicita ^a   Riccobene, Raffaella ^a   Vadalà, Anna ^a   Lorito, Maria C ^a   Raspanti, Francesco ^a   Cerasola, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adhesion molecules; Angiotensin II; Endothelial function; Endothelin 1; Nitric oxide

Indexed keywords

ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; BIOCHEMICAL MARKER; CHOLESTEROL; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FIBRINOGEN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; AUTOCRINE EFFECT; BIOCHEMISTRY; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM; ENDOTHELIUM INJURY; ESSENTIAL HYPERTENSION; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MALE; PARACRINE SIGNALING; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANGIOTENSIN II; CASE-CONTROL STUDIES; COHORT STUDIES; E-SELECTIN; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE; MALE; MIDDLE AGED; NITRIC OXIDE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 0036868164     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gomez-Cerezo J, Rios Blanco JJ, Suarez Garcia I. Non invasive study of endothelial function in white coat hypertension. Hypertension 2002, 40: 304-9.
2. Taddei S, Virdis A, Mattei P. Vasodilation to acetylcholine in primary and secondary hypertension. Hypertension 1993, 21: 929-33.
3. Morris ST, McMurray JJ, Rodger RS, Jardine AG. Impaired endothelium-dependent vasodilation in uraemia. Nephrol Dial Transplant 2000, 15: 1194-200.
4. Cross JM, Donald A, Vallance PJ, Deanfield JE, Woolfson RG, MacAllister RJ. Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001, 16: 1823-9.
5. Dohi YA, Hahn WA, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992; 19: 131-7.
6. Malek AM, Alper SI, Izumo S. Haemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035-42.
7. Morawietz H, Goetsch W, Szibor M. Angiotensin converting enzyme inhibition therapy presents upregulation of endothelin-converting enzyme-1 in failing human myocardium. Biochem Biophys Res Commun 2002; 295: 1057-61.
8. Fukuda N, Hu WY, Kubo A, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K. Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells. Am J Hypertens 2000; 13: 191-8.
9. Ketteler M, Noble NA, Border WA. Transforming growth factor-β and Angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995; 57: 279-95.
10. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2646-54.
11. Barton M, Vos I, Shaw S, Boer P, D'Uscio LV. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 2000; 11: 835-46.
12. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999; 279: 119-24.
13. De Kossodo S. WHO Collaborative Study Group: Assaying tumor necrosis factor concentration in human serum. A WHO International Collaborative Study. J Immunol Methods 1995; 182: 107-11.
14. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G. Low nitric oxide production in patients with chronic renal failure. Nephron 1998; 79: 265-8.
15. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-9.
16. Jacobson SH, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22: 42-7.
17. Stenvikel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000; 15: 1624-30.
18. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P. A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998; 29: 2129-35.
19. Ikata J, Wakatsuki T, Oishi Y, Oki T, Ito S. Leucocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 2000; 11: 445-9.
20. Blankeberg S, Rupprechy HJ, Bickel C, Peetz D, Hafner G, Tiret IJ. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-42.
21. Morisaki N, Saito I, Tamura K. New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM) and soluble vascular adhesion molecule-1 (VCAM) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997; 131: 43-8.
22. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
23. Iwasa S, Fan J, Shimokama T, Nagata M, Watanabe T. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 2000; 146: 93-100.
24. Koyanagy M, Egashira K, Kubo-Inoue M. Role of transforming growth factor in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 2000; 35: 86-90